Intestinal Hypertrophic And Anti-Inflammatory Potential Of A Novel Combination Of Long-Acting Glp-2 Analog (Hm15912) And Glp-1ra (Efpeglenatide) In Animal Models Of Inflammatory Bowel Disease. (April 2023)